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In Saccharomyces cerevisiae (budding yeast), commitment to cell division in late G1 is promoted by the G1
cyclin Cln3 and its associated cyclin-dependent kinase, Cdc28. We show here that all known aspects of the
function of Cln3 in G1 phase, including control of cell size, pheromone sensitivity, cell cycle progress, and
transcription, require the protein Swi6. Swi6 is a component of two related transcription factors, SBF and
MBF, which are known to regulate many genes at the G1-S transition. The Cln3-Cdc28 complex somehow
activates SBF and MBF, but there was no evidence for direct phosphorylation of SBF/MBF by Cln3-Cdc28 or
for a stable complex between SBF/MBF and Cln3-Cdc28. The activation also does not depend on the ability of
Cln3 to activate transcription when artificially recruited directly to a promoter. The amino terminus and the
leucine zipper of Swi6 are important for the ability of Swi6 to respond to Cln3 but are not essential for the basal
transcriptional activity of Swi6. Cln3-Cdc28 may activate SBF and MBF indirectly, perhaps by phosphorylating
some intermediary protein.
Eukaryotic cells generally enter the cell cycle at a commit-
ment point in late G1 (45, 48). In Saccharomyces cerevisiae
(budding yeast) this point is called Start. Start occurs when G1
cells reach a certain critical cell size and have a sufficiently high
rate of protein synthesis. Start coincides with a peak in the
transcription of over 200 genes, including the G1 cyclin genes
CLN1 and CLN2, the S cyclin genes CLB5 and CLB6, the HO
endonuclease gene, and a large number of genes with roles in
DNA synthesis and repair, budding, cell wall synthesis, and
spindle pole body duplication (7, 57).
A large part of the transcriptional program at Start depends
upon two transcription factors, SBF and MBF (1, 34). Many of
the genes induced at Start have multiple binding sites for SBF
and MBF in their promoters (57), and indeed, SBF or MBF
has been shown to bind to many of these genes (24, 56). SBF
and MBF are related, and both contain the protein Swi6 as a
subcomponent. They differ in that SBF contains Swi4 as the
DNA-binding protein, while MBF contains a related DNA-
binding protein called Mbp1. Swi4 and Mbp1 each have an
amino-terminal DNA binding domain, a central region con-
taining ankyrin repeats, and a carboxy-terminal region impor-
tant for binding Swi6. Swi6 does not have a DNA binding
domain, but it does have ankyrin repeats, a leucine zipper, and
a Swi4/Mbp1 interaction domain at its carboxyl terminus. SBF
and MBF have distinct preferences for DNA binding (4). The
empirically derived consensus binding sequences for SBF and
MBF are, respectively, the Swi4/6 cell cycle box element
PuNNPyCACGAAAA (41) and the MluI cell cycle box ele-
ment ACGCGTNA (27). SBF and MBF can, however, act on
each other’s recognition sequences to some extent (14). Based
on more recent genome-wide studies, the consensus sequences
for the Swi4/6 and MluI cell cycle box elements can be updated
to, respectively, CRCGAAA and ACGCGN (24, 57).
A swi4 mbp1 double mutant (which thus lacks both SBF and
MBF) is inviable, with a terminal cell cycle arrest in G1 (28),
confirming the crucial role of SBF and MBF in mediating cell
cycle entry. A very similar phenotype is found for the swi4 swi6
mutant, probably because Mbp1 is inactive in the absence of
Swi6 (28). However, both swi6 and mbp1 swi6 mutants are
viable, because Swi4 has residual activity as a transcription
factor even in the absence of Swi6 (28, 43).
The activity of SBF and MBF is regulated at many levels.
Expression of SWI4 (but not MBP1 or SWI6) varies throughout
the cell cycle, with a peak at the M-G1 transition (5). The
subcellular localization of Swi6, and therefore likely also SBF
and MBF, is regulated by phosphorylation (54, 59). The nu-
clear localization signal of Swi6 contains a phosphorylatable
serine residue. Phosphorylation of this residue, Ser160, inacti-
vates the nuclear localization signal. Since this phosphorylation
occurs in a cell cycle-regulated manner from the end of G1
until late mitosis, Swi6 is cytoplasmic from S phase to late
mitosis but is nuclear during G1 (54). However, this cell cycle-
regulated subcellular localization of SBF and MBF is not suf-
ficient to explain their activation in late G1, since in vivo foot-
printing and chromatin immunoprecipitation experiments have
shown that SBF and MBF are bound to the promoters of their
target genes in early G1 phase and yet do not induce expression
of these genes (9, 22, 29). Expression of SBF/MBF target genes
at Start involves at least three other genes, CLN3, BCK2, and
CTR9 (12, 30, 60). These genes encode putative activators of
SBF and MBF, and they may be responsible for the timing of
the transcriptional program at Start.
Cln3 is the most prominent activator of SBF and MBF. The
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CLN3 gene was originally identified by virtue of its roles in the
regulation of cell size and pheromone sensitivity (10, 40).
CLN3 transcription is only mildly cell cycle regulated, with a
peak in late M or early G1, and Cln3 protein can be detected
throughout the cell cycle (37, 60). Cln3 is a highly unstable
protein that localizes to the nucleus (15, 38, 61). Changes in the
level of Cln3 expression result in closely correlated changes in
the transcription of several hundred Start-specific genes (13,
57, 58, 60). In fact, all known transcriptional targets for SBF
and MBF can be induced by overexpression of CLN3, even in
the absence of passage through Start (57). Furthermore, the
activation of SBF and MBF in late G1 has been shown to be
dependent upon Cdc28 (29, 36), strongly suggesting that the
Cln3-Cdc28 complex is responsible. Cosma and colleagues
have recently shown that this Cdc28-mediated activation coin-
cides with the recruitment of PolII, TFIIB, and TFIIH to
SBF/MBF-regulated promoters (9).
In addition to its role in promoting transcription of Start-
specific genes, Cln3 has been shown to function as a dosage-
dependent regulator of cell size, of pheromone sensitivity, of
budding, and of the initiation of S phase (10, 40, 60). cln3
mutants are characterized by a large cell size, an increased
sensitivity to mating pheromone, and a delay at the G1-S tran-
sition (10, 40). It is not clear to what extent these phenotypes
are downstream effects of the role of Cln3 as an activator of the
transcription factors SBF and MBF and to what extent they are
separate effects of Cln3; this is one of the major issues we
address.
Cln3 is not the only activator of SBF and MBF. In a cln3 null
mutant, the expression of SBF- and MBF-regulated genes is
delayed, but there is enough residual, CLN3-independent,
SBF/MBF activity to allow cell cycle progression and cell via-
bility. The difference between the phenotype of a cln3 mutant
(which is viable) and of a swi4 mbp1 mutant (which is inviable)
indicates the existence of additional activators of SBF and
MBF. BCK2 and CTR9 encode activators of SBF and MBF
that are essential for viability in the absence of CLN3; that is,
bck2 cln3 and ctr9 cln3 double mutants are each inviable (12,
17, 30).
Although a role for Cln3 in the activation of SBF/MBF-
mediated transcription has been recognized in previous stud-
ies, it has remained unclear to what extent the various aspects
of Cln3 function depend on SBF and MBF. In addition, little
or nothing is known about the mechanism by which Cln3 ac-
tivates SBF and MBF. The work presented here has been
directed at determining whether Cln3 acts exclusively via SBF
and MBF and at uncovering the mechanism by which Cln3
activates SBF and MBF. We found that all known aspects of
the function of CLN3 require SWI6. Our work suggests that
Cln3-Cdc28 may not activate SBF and MBF by direct phos-
phorylation or by forming a stable complex with SBF or MBF.
Mutational analysis of SWI6 has allowed us to uncover roles
for the amino terminus and the leucine zipper region of Swi6
in responding to Cln3.
MATERIALS AND METHODS
Yeast strains, culture conditions, and plasmids. The yeast strains used in this
study are listed in Table 1. We used standard methods for culture and manipu-
lation of yeast (21). Carbon sources were generally used at a combined final
concentration of 2% (wt/vol). Synthetic complete (SC) dropout media were
prepared by addition of 2.0 g of a mix containing the appropriate amino acids to
5 g ammonium sulfate and 6.7 g of Difco-Bacto yeast nitrogen base lacking
amino acids and ammonium sulfate. The final concentrations of amino acids and
bases in the media were 50 mg/liter, except for L-tryptophan (80 mg/liter),
adenine sulfate (32 mg/liter), and p-aminobenzoic acid (5 mg/liter). YAP-based
media were made by supplementing YEP (1% yeast extract, 2% peptone)-based
media with filter-sterilized adenine to 0.004% (wt/vol). YAPD medium was YAP
with 2% D-glucose. Plasmids were created by using a combination of standard
restriction fragment cloning methods, PCR, in vitro mutagenesis, and in vivo gap
repair cloning (2, 35, 51).
For the experiment shown in Fig. 8, plasmid pHW254 (Ycplac111-CLN3Not
I
)
was used to create plasmid pHW364, which contains a full-length CLN3 gene
fused at its carboxyl terminus to the TUP1 repression domain (encoding amino
acids [aa] 74 to 388).
For the studies shown in Fig. 9, plasmid pHW322 (pGBD-C1-SWI61-803 SWI6)
was used to create a series of GAL4BD-SWI6 deletion mutants. The resulting
mutant plasmids are pHW344 (pGBD-C1-SWI61-715 SWI6C), pHW350
(pGBD-C1-SWI61-568 SWI6LZC), pHW359 (pGBD-C1-SWI61-281 SWI6ALZC),
pHW351 (pGBD-C1-SWI61-193 SWI6NALZC), pHW354 (pGBD-C1-SWI6284-803
SWI6N), pHW353 (pGBD-C1-SWI6561-803 SWI6NA), pHW360 (pGBD-C1-
SWI6284-715 SWI6NC), pHW363 (pGBD-C1-SWI6715-803 SWI6NALZ),
pHW362 (pGBD-C1-SWI6561-715 SWI6NAC), pHW374 (pGBD-C1-
SWI6561-583/610-803 SWI6NALZ), and pHW373 (pGBD-C1-SWI6284-583/610-803
SWI6NLZ). A limited series of SWI6 deletion mutants under control of the native
promoter was created in centromeric (YCplac33) and integrating (YIplac204) vec-
tors: pHW197 (YCplac33-SWI61-803 SWI6), pHW378 (YCplac33-SWI6561-803
SWI6NA), pHW379 (YCplac33-SWI6561-583/610-803 SWI6NALZ), pHW206
(YCplac33-SWI61-561/610-803 SWI6LZ), pHW377 (YIplac204-SWI61-803 SWI6),
pHW386 (YIplac204-SWI6561-803 SWI6NA), pHW387 (YIplac204-
SWI6561-583/610-803 SWI6NALZ), and pHW388 (YIplac204-SWI61-561/610-803
SWI6LZ).
A list of the plasmids mentioned in this study can be found in Table 2.
Northern analysis. Northern analysis was performed essentially as described
previously (63). Northern signals were quantitated using a PhosphorImager and
normalized to the ACT1 signal after subtraction of background signals.
Mutagenesis. Site-directed mutagenesis was performed using materials and
protocols of the pAlter system from Promega. Use of the pAlter system required
recloning of the targeted sequences into the pAlter vector or one of its deriva-
tives (G. Sherlock and B. Futcher, unpublished results) that contained yeast
auxotrophic markers.
Plasmid pHW143 (pYLeuAlter1-SWI6) was subject to site-directed mutagen-
esis to create derivatives with mutations in the Cdc28 consensus phosphorylation
sites in the SWI6 gene. Derivatives of pHW143 were created with a NotI restric-
tion site at the SWI6 stop codon. pHW155 (SWI6n) has the carboxy-terminal NotI
site but no mutations in SP or TP dipeptides, pHW156 (SWI6s2) has the NotI site
and an S-to-A change at position 228, pHW157 (SWI6s1-2) is pHW156 with an
additional S-to-A change at position 160, pHW179 (SWI6s1-4) is pHW157 with a
T-to-A mutation at position 179 and an S-to-A mutation at position 238, and
pHW180 (SWI6s1-5) is pHW179 with a P-to-S change at position 321.
Immunoprecipitation and immunoblot analysis. Yeast extracts for immuno-
precipitations and immunoblot analysis were prepared as specified previously
(60). Yeast pellets were lysed in a mini-Beadbeater cell disrupter (Biospecs) with
0.5-mm-diameter acid-washed baked zirconium beads in the presence of buffer 3
(0.1% NP-40, 250 mM NaCl, 50 mM NaF, 5 mM EDTA, and 50 mM Tris-HCl
[pH 7.5]) and proteinase inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 g of
leupeptin per ml, 1 g of pepstatin per ml, 0.6 mM dimethylaminopurine, 10 g
of soybean trypsin inhibitor per ml, and 1 g of tosylsulfonyl phenylalanyl
chloromethyl ketone per ml). Cell debris was pelleted during a 15-min micro-
centrifuge spin at maximum speed. Protein concentrations were quantitated
using the Bio-Rad dye-binding assay according to the manufacturer’s specifica-
tions. Immunoprecipitations were carried out with 2 to 6 mg of extract by adding
0.3 l of ascites fluid containing 12CA5 or 9E10 mouse monoclonal antibody and
incubating on ice for 2 h. Next, protein G agarose beads (Pharmacia) were
added, and the extracts were rocked at 4°C for 2 h. Beads were washed four times
with buffer 3, using pulse spins of 1,000  g in a microcentrifuge. Protein
samples (40 g for immunoblots) were mixed with 2 loading buffer boiled for
1 to 2 min and subjected to sodium dodecyl sulfate–10% polyacrylamide gel
electrophoresis. Protein gels were transferred to nitrocellulose by using a semidry
transfer apparatus (Millipore) and probed consecutively with primary (1:10,000
diluted 12CA5 or 9E10 antibody or 1:100 diluted Santa Cruz sc-53 polyclonal
antibody) and secondary (1:20,000 Amersham horseradish peroxidase-conju-
gated sheep anti-mouse or goat anti-rabbit immunoglobulin G) antibodies. Pro-
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teins were visualized using the Amersham ECL system or the Pierce Supersignal
system according to the manufacturer’s specifications.
Cell cycle synchrony experiments. Cell cycle synchronizations were performed
using centrifugal elutriation as described previously (60). Synchrony was con-
firmed using microscopic analysis and flow cytometry.
For the experiment shown in Fig. 2, in order to obtain cultures of desirable
morphology and starting cell size for elutriation and to control for a possible
effect of the swi6 mutation on SWI4 expression, strains YHW29 and YHW30
were engineered to contain an integrated MET3-CLN2 construct and an episo-
mal {S.pADH-SWI4-URA3-CEN} plasmid (CB1491). Initial cultures of YHW29
and YHW30 were grown in SC medium lacking uracil (SCura) with 2% raf-
finose and containing 0.001% (wt/vol) methionine, which allows for limited
induction of MET3-CLN2. Methionine (2 mM final concentration) was added 10
min before harvesting of the cultures for elutriation to repress MET3-CLN2
during the rest of the experiment.
Flow cytometry. Flow cytometry with a FACSCalibur flow cytometer (Becton
Dickinson) was performed on yeast cells stained with propidium iodide. After
yeast cells had been harvested, washed, sonicated, and fixed overnight in 70%
ethanol at 4°C, they were resuspended in 50 mM sodium citrate, washed in the
same buffer, sonicated, treated with RNase A (final concentration, 0.25 mg/ml)
for 1 h at 50°C, and treated with proteinase K (final concentration, 1 mg/ml) for
an additional hour at 50°C. Before analysis the yeast cells were stained with
propidium iodide at a final concentration of 16 g/ml.
Cell size analysis. Analysis of the cell size distribution of yeast strains was done
using cultures in mid-log phase. Samples of the cultures were resuspended in 10
ml of Isoton buffer, briefly sonicated, and immediately analyzed using a Coulter
Counter (model ZM; 70-m aperture) and a Coulter Channelyzer (model 256).
Yeast cultures that were to be compared for their cell size distribution were
started at the same time in aliquots of the same batch of medium. Cultures were
grown to log phase, rediluted at equal densities, and allowed to grow for at least
two additional doublings. When cultures reached mid-log phase, as judged by
both spectrophotometric analysis and cell count, aliquots were taken for size
analysis. For comparison of the cell size profiles of different genotypes, we used
strains derived from the same genetic background.
RESULTS
Cln3 functions via the Swi6 subcomponent of SBF and
MBF. Cyclin-Cdk complexes are conserved regulators of Start-
specific transcription (65). In budding yeast, Cln3-Cdc28 com-
plexes regulate the activity of SBF and MBF (60). We hypoth-
esized that all functions of Cln3 might depend on the Swi6
subcomponent of SBF and MBF on the basis of two published
observations: (i) the morphology and growth of swi6 and swi6
cln3 mutants are similar, suggesting that Cln3 and Swi6 might
function in the same linear pathway (43), and (ii) the ability of
CLN3-1, a stabilizing allele of CLN3, to regulate pheromone
sensitivity depends on SWI6 (43). To determine whether Cln3
acts via Swi6, the effect of varying the CLN3 dosage was tested
in the presence and absence of SWI6. All relevant aspects of
CLN3 function were found to be dependent on SWI6.
TABLE 1. S. cerevisiae strains
Strain Backgrounda Relevant genotype Source
MAV99 MATa trp1-901 leu2-3,112 his200 ade2-101 gal4 gal80 can1r
cyh2r LYS2::(GAL1::HIS3) GAL1::lacZ
SPO13::10xGAL4site::URA3
M. Vidal
PJ69-4A MATa trp1-901 leu2-3,112 ura3-52 his3-200 gal4 gal80
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ
P. James
RN200-6d MATa cdc34-2 his3 leu2 ura3 R. Nash
W303a MATa ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 ssd1-d R. Rothstein
W303Va MATa ade2-1 his3-11,15 leu2-3,112 trp1-1 ura3-1 SSD1-v K. Arndt
YHW23 MATa ade2-101 his3200 leu21 lys2-801 ssd1-d ura3-52 swi6::HIS3
swi4::HIS3 {YCplac33/GAL1-10-3xHA-SWI4}
This study
YHW29 W MATa cln3::ura3-GAL1-CLN3 trp1::MET3-CLN2-TRP1 {YCp50/
S.pADH-SWI4}
This study
YHW30 W MATa cln3::ura3-GAL1-CLN3 trp1::MET3-CLN2-TRP1 swi6::LEU2
{YCp50/S.p.ADH-SWI4}
This study
YHW31 MAT ade2-101 his3200 leu21 lys2-801 ssd1-d ura3-52 swi6::HIS3 This study
YHW95 V MATa swi4::HIS3 This study
YHW97 V MATa swi6::LEU2 This study
YHW204 MAT ade2 his3-11,15 leu2 trp1 ura3 cln3::ura3 bck2::TRP1
{pRS313/MET3-CLN2}
This study
YHW228 MATa ade2-101 his3200 leu21 lys2-801 ssd1-d swi6::HIS3
swi4::HIS3 CLN2::MET-CLN2
This study
YHW446 V MATa swi6::LEU2 cln3::hisG-URA3-hisG This study
YHW541 MATa ade2-1his3-11,15 leu2 trp1 ura3 SSD1-v bck2::TRP1
swi6::LEU2 {pRS313/MET3-CLN2}
This study
YHW613 MAT ade2 his3-11,15 leu2 trp1 ura3 cln3::ura3 bck2::TRP1
swi6::LEU2 {pRS313/MET3-CLN2}
This study
YHW623 P MATa cln3::hisG This study
YHW626 V MATa swi6::leu2::hisG-URA3-hisG This study
YHW665 V MATa cln3::hisG-URA3-hisG This study
YHW668 P MATa cln3::hisG swi6::leu2::hisG-URA3-hisG This study
YHW731 P MATa cln3::hisG {pGBDU-C2/CDC28} This study
YHW838 MATa ade2-101 his3200 leu21 lys2-801 ssd1-d ura3-52 trp1::URA3
swi6::HIS3 swi4::HIS3 CLN2::MET3-CLN2
This study
YHW888 W MATa cln3::ura3-GAL1-CLN3 swi6::LEU2 trp1::TRP1 This study
YHW889 W MATa cln3::ura3-GAL1-CLN3 swi6::LEU2 trp1::SWI6-TRP1 This study
a Strains with background P are isogenic to PJ69-4A (25), strains with background V are isogenic to W303Va, strains with background V3 have been backcrossed
three times to W303Va, and strains with background W are isogenic to W303a. The difference between W303Va (SSD1-v) and W303a (ssd1-d) is important for this
study, since a cln1 cln2 SSD1-v strain is viable but a cln1 cln2 ssd1-v strain is inviable (18).
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Regulation of cell size by CLN3 depends on SWI6. CLN3 is
a dosage-dependent regulator of the length of G1 and of cell
size (40, 48). Whether this control of cell size by CLN3 de-
pends on SWI6 was determined by comparing the average cell
size of swi6 mutants with that of cln3 swi6 mutants. Both
mutants have the same cell size (Fig. 1A). Likewise, overex-
pression of CLN3 from a multicopy plasmid led to a reduced
average cell size in the presence of SWI6 but not in the absence
of SWI6 (Fig. 1B). Thus, neither under- nor overexpression of
CLN3 affects cell size in the absence of SWI6. This effect was
specific to SWI6, because overexpression of CLN3 could re-
duce the average cell size of swi4 mutants (data not shown).
In a second approach, elutriation was used to obtain small
G1-phase daughter cells from SWI6 and swi6 strains carrying
GAL-CLN3. Cells were grown and G1 cells were obtained in
the absence of galactose (CLN3 off), and then half of the G1
cells from each strain were exposed to galactose (CLN3 on).
Budding was assayed as an indicator of Start as the small G1
cells grew. As expected, the induction of CLN3 allowed cells to
pass through Start (here defined as 50% budding) at a reduced
cell size in the SWI6 cells. However, induction of CLN3 had
little or no effect in the swi6 mutant cells (Fig. 2).
Regulation of pheromone sensitivity by CLN3 depends on
SWI6. In haploid cells, CLN3 regulates sensitivity to phero-
mone (10, 40). Haploid cells exposed to pheromone arrest in
late G1 at Start and attempt to conjugate (32). This G1 arrest
TABLE 2. Plasmids
Name Vectora Insert Reference or source
pGBD-C1 pGBD-C1 25
pPC97 pPC97 6
pYLeuAlter1 pYLeuAlter1 G. Sherlock
YCp50 YCp50 49
YCplac111 YCplac111 19
YEplac195 YEplac195 19
YEp352 YEp352 23
C2691 YCplac33 GAL1-10-3xHA-SWI4 K. Nasmyth
CB1491 YCp50 S.p ADH-SWI4 18
pGBDU-C2-CDC28 pGBDU-C2 CDC28 G. Sherlock
pML1 pRS313 MET3-CLN2 This study
pMT41 YEp24 GAL1-10-CLN3::3xHA(carboxy-terminal) M. Tyers
YEp352#5 YEp352 CLN3 R. Nash
YEp352#11 YEp352 CLN3-1 R. Nash
pHW126 pRS304 MET3-CLN2 This study
pHW136 pRS426 SWI6 This study
pHW143 pYLeuAlter1 SWI6 This study
pHW155 pYLeuAlter1 SWI6n (SWI6 with NotI site at carboxyl terminus) This study
pHW156 pYLeuAlter1 SWI6s2 (SWI6n with S2283A) This study
pHW157 pYLeuAlter1 SWI6s1–2 (SWI6s2 with S1603A) This study
pHW179 pYLeuAlter1 SWI6s1–4 (SWI6s1–2 with T1793A and S2383A) This study
pHW180 pYLeuAlter1 SWI6s1–5 (SWI6s1–4 with P3213S) This study
pHW197 YCplac33 SWI6 This study
pHW206 YCplac33 SWI6LZ (encoding aa 1–561 and 610–803) This study
pHW254 YCplac111 CLN3NotI (CLN3 with NotI site at carboxyl terminus) This study
pHW262 YEplac181 SWI6 This study
pHW263 YEplac181 SWI6-6x(myc) This study
pHW322 pGBD-C1 SWI6 This study
pHW344 pGBD-C1 SWI6C (encoding aa 1–715) This study
pHW350 pGBD-C1 SWI6LZC (encoding aa 1–568) This study
pHW351 pGBD-C1 SWI6NALZC (encoding aa 1–193) This study
pHW353 pGBD-C1 SWI6NA (encoding aa 561–803) This study
pHW354 pGBD-C1 SWI6N (encoding aa 284–803) This study
pHW355 pPC97 CLN3-1::3xHA This study
pHW359 pGBD-C1 SWI6ALZC (encoding aa 1–281) This study
pHW360 pGBD-C1 SWI6NC (encoding aa 284–715) This study
pHW362 pGBD-C1 SWI6NAC (encoding aa 561–715) This study
pHW363 pGBD-C1 SWI6NALZ (encoding aa 715–803) This study
pHW364 YCplac111 CLN3-TUP1 (CLN3NotI with TUP1 encoding aa 74-388
at NotI site)
This study
pHW373 pGBD-C1 SWI6NLZ (encoding aa 284–583 and 610–803) This study
pHW374 pGBD-C1 SWI6NALZ (encoding aa 561–583 and 610–803) This study
pHW377 YIplac204 SWI6 This study
pHW378 YCplac33 SWI6NA (encoding aa 561–803) This study
pHW379 YCplac33 SWI6NALZ (encoding aa 561–583 and 610–803) This study
pHW386 YIplac204 SWI6NA (encoding aa 561–803) This study
pHW387 YIplac204 SWI6NALZ (encoding aa 561–583 and 610–803) This study
pHW388 YIplac204 SWI6LZ (encoding aa 1–561 and 610–803) This study
a References are as follows: pGBDU-C2, 25; YCp50, 49; YEp24, 3; YCplac111, YCplac33, YEplac181, YEplac195, and YIplac204, 19; pRS304 and pRS313, 55; and
pRS426, 8.
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involves the inactivation of Cln-Cdc28 complexes. CLN1 and
-2 are inhibited at the transcriptional level (16, 62, 64) as well
as posttranslationally (47), whereas CLN3 is inhibited solely at
the posttranslational level (16, 26). Part of the transcriptional
inhibition of CLN1 and CLN2 is likely due to the loss of
Cln3-Cdc28 activity. cln3 mutants have enhanced sensitivity to
pheromone, whereas cells with increased Cln3 dosage are
more resistant (10, 40). Deletion of SWI6 leads to an increase
in pheromone sensitivity that is comparable to that observed in
the absence of CLN3. To determine whether Cln3 regulates
pheromone sensitivity by regulating SBF and MBF (and thus
the expression of CLN1 and CLN2), the effect of CLN3 dosage
on pheromone sensitivity was determined in the presence and
absence of SWI6 (Fig. 3). It was found that high-copy overex-
pression of CLN3 caused increased pheromone resistance in
the presence of SWI6 but not in the absence of SWI6. Similarly,
CLN3-1 affected pheromone sensitivity preferentially in the
presence of SWI6 (Fig. 3A). CLN3-1 does increase pheromone
resistance slightly even in the absence of SWI6, but this appears
to be a neomorphic effect associated with the CLN3-1 allele
(see Discussion) (15). Moreover, when cln3 and swi6 mutations
were combined, no increase in pheromone sensitivity was ob-
served (Fig. 3B), which suggests that these genes may function
at different levels in the same linear pathway. These results
suggest that CLN3 regulates pheromone sensitivity upstream
of SWI6 (Fig. 3A) and in the same pathway (Fig. 3). The
specificity of these results is illustrated by the ability of high-
copy CLN3 to regulate pheromone sensitivity efficiently in the
absence of SWI4 (Fig. 3A) (when CLN3 presumably works via
SWI6 and MBP1) and the ability of BCK2, another regulator of
Start, to efficiently reduce pheromone sensitivity in the absence
of SWI6 (63).
Regulation of S phase and budding by CLN3 depends on
SWI6. CLN3 is a dosage-dependent activator of Start (40). To
confirm that the ability of CLN3 to regulate the length of G1
phase fully depends upon SWI6, the effect of altering CLN3
dosage on S phase and budding was determined in both SWI6
and swi6 strains. Cell cycle distributions of asynchronous cul-
tures of wild-type, cln3, swi6, and swi6 cln3 yeast strains were
assayed by using flow cytometry and propidium iodide staining
of DNA (Fig. 4). Deletion of CLN3 affected cell cycle distri-
bution in the SWI6 strain but not in the swi6 strain. The time
of budding was determined in the cell cycle synchronization
experiment described in Fig. 2 by comparing uninduced and
induced GAL1-CLN3 SWI6 and GAL1-CLN3 swi6 G1 cultures
for the time when 50% of the cells were budded (Fig. 2C). The
time of 50% budding was affected by CLN3 expression in the
presence of SWI6 but not in the absence of SWI6, suggesting
that Cln3’s sole effect on cell cycle progress is via the activation
of Swi6 (Fig. 2C). A similar experiment using a different ge-
netic background is described in Fig. 5. In agreement with the
results described in Fig. 2, galactose induction of GAL1-CLN3
affected the timing of DNA replication (Fig. 5A) and budding
(Fig. 5B) only in the presence of SWI6.
Induction of transcription by CLN3 depends on SWI6. A
genome-wide analysis of gene expression has shown that Cln3
was capable of inducing the expression of over 200 genes with
a Start-specific transcription pattern (57). It has not been de-
termined which of these inductions are primary effects, but
many of the putative Cln3 targets may be regulated via SBF
and MBF. In a previous study we found that the ability of
CLN3 to induce its target genes CLN1, PCL1, and RNR1 is
eliminated in a swi4 mbp1 strain, which has no functional Swi6
(63). To determine if Cln3’s ability to induce transcription
specifically depends on Swi6, we assayed the effect of increased
Cln3 expression on the mRNA levels of SBF and MBF target
FIG. 1. The effect of CLN3 on cell size depends on SWI6. (A) Iso-
genic strains W303Va (wild type [wt]), YHW97 (swi6), and YHW446
(swi6 cln3) were grown to mid-log phase in YAPD medium and ana-
lyzed for their cell size.(B) Isogenic strains W303Va (wt), and YHW97
(swi6) were transformed with either a high-copy CLN3 plasmid
(YEp352#5) or a vector control (YEplac195). Transformants were
grown to mid-log phase in SCura with 2% glucose and analyzed for
their cell size.
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genes in both SWI6 and swi6 strains. G1-phase SWI6 or swi6
cells were obtained by elutriation, and the expression of CLN1,
RNR1, and PCL1 was assayed with and without induction of
GAL1-CLN3 (Fig. 5). Induction of GAL1-CLN3 shifted the
expression of these target genes to a smaller cell size in the
presence of SWI6 but had no effect in the absence of SWI6
(Fig. 5C to E). (Note that the SWI6 cells cannot be compared
directly to the swi6 cells on the basis of elapsed time because of
an initial difference in cell size [see the legend to Fig. 5].)
The three chosen target genes are regulated in somewhat
different ways, and deletion of SWI6 had a distinct effect on
each of these genes. The cell cycle pattern of transcription for
CLN1 and PCL1 but not RNR1 persisted in the absence of
SWI6. Deletion of SWI6 not only shifted peak expression of
FIG. 2. The effect of CLN3 on critical cell size and timing of Start depends on SWI6. Synchronous cultures of SWI6 (YHW29) and swi6
(YHW30) versions of a strain with a galactose-inducible GAL-CLN3 allele were obtained by centrifugal elutriation. After growth and elutriation
in medium containing raffinose (Raff) (2%), the cultures containing small G1 daughter cells were split. One half was released into raffinose medium
(SCura with 2 mM Met and 2% raffinose), whereas the other half was released into medium supplemented with galactose (Gal) (2%) to induce
GAL1-CLN3. After release, samples were taken every 20 min and average cell size, budding, and DNA content were measured. (A and B) The
kinetics of budding as a function of cell size were compared for the raffinose- and raffinose-galactose-grown cultures of YHW29 (SWI6) (A) and
YHW30 (swi6) (B). The size at which 50% of the cells had budded is indicated by an arrow. (C) Estimated cell size and time after release at which
50% budding occurs.
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both CLN1 and PCL1 to a much larger cell size but also
specifically delayed the timing of PCL1 peak expression rela-
tive to that of CLN1 (cf. Fig. 5C and D). The differential effects
of SWI6 deletion on the regulation of the three selected target
genes may be explained by their relative dependence on reg-
ulation by SBF versus MBF. SBF-regulated genes such as
CLN1 (46) are more likely to benefit from the residual activity
of Swi4 (which persists in swi6 mutants) than predominantly
MBF-regulated genes such as RNR1 (14, 33). SBF-responsive
genes that can also be regulated by MBF, such as PCL1 (63),
have an intermediate response to deletion of SWI6. Thus, it is
particularly striking that in spite of these gene-specific differ-
ences , all three genes responded to CLN3 only in the presence
of SWI6.
We also induced GAL1-CLN3 in arrested cultures of cln3
bck2 or cln3 bck2 swi6 strains. GAL1-CLN3 enhanced the
expression of CLN1, PCL1, RNR1, and CLB5 in the SWI6
strain but had no effect in the swi6 strain (data not shown).
Regulation of Swi6 by Cln3 does not depend on the consen-
sus Cdc28 phosphorylation sites of Swi6. Having established
that Cln3 exerts its function via the Swi6 subcomponent of SBF
and MBF, we wanted to address the mechanism by which Cln3
activates Swi6. The biochemical role of Cln3 is to activate the
Cdc28 protein kinase, and it is clear that Cln3 requires Cdc28
FIG. 3. The effect of CLN3 on pheromone sensitivity depends on SWI6. (A) Isogenic strains W303Va (wild type [wt]), YHW95 (swi4), and
YHW97 (swi6) were transformed with high-copy (hc) plasmids containing no insert (YEplac195), CLN3 (YEp352#5), or CLN3-1 (YEp352#11).
Transformants were grown to mid-log phase in SCura with 2% (wt/vol) glucose. Aliquots of 1,000 cells from each culture were spotted on YAPD
plates containing 0, 3, or 30 M -factor. The picture was taken after 2.5 days of incubation at 30°C. (B) The pheromone sensitivities of isogenic
wild-type (W303Va), cln3 (YHW665), swi6 (YHW97), and cln3 swi6 (YHW446) strains were compared by spotting aliquots of 10,000 cells for each
of these strains onto YAPD plates containing either 0 or 3 M -factor.
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in order to induce SBF- or MBF-dependent transcription (11,
60). Thus, the most obvious model is that the Cln3-Cdc28
complex directly phosphorylates Swi6, or perhaps Swi6 and
also Swi4 and Mbp1, and that this causes activation of tran-
scription. Work by Sidorova and colleagues (54) showed that
Swi6 is regulated in part by phosphorylation. This particular
phosphorylation, however, does not reflect activation by Cln3-
Cdc28 but rather reflects inactivation of the nuclear localiza-
tion signal of Swi6 by an unspecified kinase (54).
Swi6 has five SP or TP sites (i.e., the minimal recognition
motif for Cdc28-cyclin complexes). To test the idea that phos-
phorylation of Swi6 by Cln3-Cdc28 was important for tran-
scriptional activation, we made a quintuple SWI6 mutant lack-
ing all five sites. Four of the sites were changed to AP. For the
fifth site, which resides in one of Swi6’s ankyrin repeats and has
a conserved threonine, the proline residue was mutated to
serine. The resulting quintuple phosphorylation site mutant (as
well as various other combinations of phosphorylation site
mutations) was tested for function in several assays. As shown
in Fig. 6, cells bearing the quintuple SWI6 mutant have exactly
the same cell size distribution as cells with wild-type SWI6. In
addition, we assayed the ability of the quintuple mutant to
respond to the presence of CLN3 by measuring cell size in the
presence and absence of CLN3. The quintuple mutant SWI6
was fully responsive to CLN3 (data not shown). In addition,
the quintuple mutant SWI6 was indistinguishable from wild-
type SWI6 in its ability to rescue swi4 swi6 and bck2 swi6
mutants. The quintuple mutant SWI6 and wild-type SWI6 were
also indistinguishable with regard to cell cycle distribution and
cell morphology, even in an mbp1 background (data not
shown).
The results described above suggest that Cln3-Cdc28 does
not work solely by phosphorylating Swi6 on SP or TP sites. We
therefore also examined the role of potential phosphorylation
sites in Swi4. There are many SP and TP sites in Swi4, but M.
Neuberg and K. Nasmyth (personal communication) previ-
ously mapped cell cycle-regulated phosphopeptides on Swi4,
discovered two Cdc28-dependent phosphorylations, and mapped
FIG. 4. The effect of CLN3 on cell cycle distribution depends on SWI6. Wild-type (W303Va), cln3 (YHW665), swi6 (YHW97), and cln3 swi6
(YHW446) strains of isogenic backgrounds were grown to log phase in YAPD medium at 30°C. The DNA content of the cultures was determined
by flow cytometry of propidium iodide-stained samples. The relative number of cells with a 1N DNA content was used as an estimate for the
percentage of cells in G1.
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them to S159 and T799. We obtained the SWI4 S159A T799V
double mutant (SWI4*) from Neuberg and Nasmyth, combined it
with the quintuple SWI6 mutant (SWI6s1-5), and examined the
responsiveness of this combination to CLN3-1. Because the pres-
ence of Mbp1 could potentially interfere with interpretation, we
did these experiments in an mbp1 background. Experiments were
done in the presence of the resident copy of CLN3, with or
without an added copy of CLN3-1. The results showed that the
SWI4* mutation had no effect on cell size and also no effect on the
ability of CLN3-1 to affect cell size. For example, the mode cell
size of the CLN3-1 SWI4 SWI6s1-5 CLN3 mbp1 strain was 0.80 of
the mode cell size of its SWI4 SWI6s1-5 CLN3 mbp1 control, while
the mode cell size of the CLN3-1 SWI4* SWI6s1-5 CLN3 mbp1
strain was 0.81 of the mode cell size of its SWI4* SWI6s1-5 CLN3
mbp1 control. These two ratios, 0.80 and 0.81, are not significantly
different. Thus, we can find no evidence that Cln3-Cdc28 exerts its
effect by phosphorylating any component of SBF. We acknowl-
edge that, formally, we cannot rule out the possibility that other,
untested sites on Swi4 or non-SP/TP sites on Swi6 could be in-
volved (although no such sites were noted by Sidorova et al. [54]).
Stable complexes between Cln3 and Swi6 cannot be de-
tected. Activation of Swi6 by Cln3-Cdc28 could involve a phys-
ical interaction between Cln3-Cdc28 and SBF or MBF. If Cln3-
Cdc28 did bind to SBF or MBF, the resulting complex would
FIG. 5. Effect of CLN3 on cell cycle progress and Start-specific transcription in SWI6 and swi6 cells. After growth and centrifugal elutriation
in YAP with 2% raffinose, cln3::GAL1-CLN3 SWI6 (YHW889) and cln3::GAL1-CLN3 swi6 (YHW888) cells were released into either YAP–2%
raffinose (Raff) or YAP–2% raffinose–2% galactose (Raff/Gal) medium. Because the swi6 mutation affects cell size at cytokinesis, elutriated cells
from the swi6 strain were larger than elutriated cells from the SWI6 strain; thus, the left and right panels cannot be directly compared on the basis
of elapsed time. Samples were taken every 20 min, and DNA content (A), budding index (B), and cell size were measured. (A) Histograms of DNA
content from samples taken 20 min apart. (B) Budding as a function of time. (C to E) The same samples were also processed for Northern analysis.
Blots were hybridized with DNA fragments corresponding to the ACT1, CLN1, PCL1, and RNR1 genes, and hybridization signals were quantitated
using a Fuji PhosphorImager. The signals for the Start-specific transcripts CLN1, PCL1, and RNR1 were normalized to ACT1 (loading control).
Expression of CLN1, PCL1, and RNR1 is shown as a function of time in, respectively, panels C, D, and E. Peak expression levels of CLN1 and
PCL1 corresponded to the following approximate average cell sizes in each of the four conditions: SWI6 Raff, CLN1 peak at a volume of 50 fl
and PCL1 peak at 55 fl; SWI6 Raff/Gal, CLN1 peak at 45 fl and PCL1 peak at 45 fl; swi6 Raff, CLN1 peak at 85 fl and PCL1 peak at 100
fl; and swi6 Raff/Gal, CLN1 peak at 85 fl and PCL1 peak at 100 fl.
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FIG. 5—Continued.
VOL. 22, 2002 TRANSDUCTION OF Cln3 FUNCTION BY Swi6 4411
likely be found at the promoters of SBF and MBF target genes,
because in vivo footprinting and chromatin immunoprecipita-
tion assays have shown that SBF is found on the promoters of
its target genes throughout G1 (9, 22, 29). We looked for stable
complexes between Cln3-Cdc28 and SBF or MBF by immuno-
precipitating epitope-tagged versions of Swi6 and looking for
coprecipitation of Cdc28 or epitope-tagged Cln3. Even when
both Cln3 and Swi6 were overexpressed in cultures with a large
fraction of G1 cells, no such coprecipitation was seen (Fig. 7).
In the same experiments, Cln3-Cdc28 complexes and Swi4-
Swi6 complexes were readily detected by coimmunoprecipita-
tion (Fig. 7).
We have also attempted chromatin cross-linking immuno-
precipitation experiments to see if hemagglutinin (HA)-tagged
FIG. 6. Swi6 is not activated via its Cdc28 consensus phosphorylation sites. (A) Strain YHW31 (swi6) was transformed with plasmids pHW155
({LEU2-CEN-SWI6n}, all five SP or TP sites present) and pHW180 ({LEU2-CEN-SWI6s1-5}, all five SP or TP sites mutated [see Materials and
Methods]). Transformants were grown to log phase in SCleu with 2% glucose and analyzed for cell size. As a control, cell size was measured
for a culture of untransformed YHW31 (swi6) grown in the same medium supplemented with 0.01% leucine. (B) Strain YHW23 (swi4 swi6
{GAL1-SWI4-CEN}) was transformed with pYLeuAlter1 (vector) and its derivatives pHW143 (SWI6), pHW155 (SWI6n, no sites mutated),
pHW157 (SWI6s1-2, two sites mutated), pHW179 (SWI6s1-4, four sites mutated), pHW180 (SWI6s1-5, five sites mutated), and pHW156 (SWI6s2, one
site mutated). The resulting strains were grown in SCleu with 1% raffinose and 1% galactose. Serially diluted aliquots of cells were spotted on
either SCleu with 1% raffinose and 1% galactose (Leu Raff/Gal) or SCleu with 2% glucose (Leu Gluc) plates and were photographed after
3 days at 30°C.
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Cln3 could be specifically cross-linked to an SBF-regulated
promoter. Results have been negative, but because of the high
background in these experiments (i.e., the presence of DNA
from the target promoter in immunoprecipitates from the un-
tagged control), we place no weight on these negative results.
Is Cln3 a direct transcriptional activator? In the course of
other work, Cln3 was fused to a DNA-binding protein for the
purpose of a two-hybrid screen. It was found that under this
artificial condition, Cln3 is a powerful transcriptional activator
(data not shown). We considered the possibility that this ac-
tivity reflected a relevant aspect of Cln3 function. Perhaps
Cln3-Cdc28 is targeted to SBF- and MBF-dependent promot-
ers (possibly by a weak interaction with SBF and MBF) and,
once at the promoter, Cln3 operates relatively directly as a
transcriptional activator. To test this possibility, we fused full-
length Cln3 to the Tup1 repression domain (aa 74 to 388).
Whereas wild-type Cln3 increased transcription of a reporter
gene when recruited to its promoter by a Gal4BD-Cdc28 fu-
sion protein (Gal41-147-Cdc28), the Cln3-Tup1 fusion protein
had no such effect (Fig. 8C), showing that the Tup1 repression
domain was effective in this context. That is, in contrast to
Cln3, Cln3-Tup1 is not a transcriptional activator. However,
Cln3 and Cln3-Tup1 were equally effective in rescuing the
viability of cln1 cln2 cln3 or bck2 cln3 strains and were equally
effective in promoting Start, as assayed by cell size and cell
cycle distribution (Fig. 8A and B and data not shown). (These
results also weakly suggest that Cln3 does not form a long-lived
complex with SBF and MBF at target promoters; if it did, then
the Tup1 repression domain would likely have interfered with
transcription of these targets.)
In a second approach, we mutagenized Cln3 in an attempt to
separate its normal cell cycle role from its ability to activate
transcription when fused to a DNA binding domain. We
started with a CLN3 fusion construct that lacked the PEST
region previously associated with part of CLN3’s transactivat-
ing activity (GAL41-147::CLN3-1::3xHA; pHW355) (50). The
fusion protein expressed by this construct provides Cln3 func-
tion and also activates transcription at Gal4-driven promoters
(Table 3). We then identified point mutations in the CLN3
portion of the fusion gene that eliminated the transactivation
activity of the fusion protein. We found that there was no
correlation between the behavior of fusion proteins in assays
for Cln3 function (rescue of bck2 cln3) and in assays for trans-
activation at Gal4-driven promoters (Table 3). Therefore, the
direct transcriptional activation activity of CLN3 is dispensable
for its normal cell cycle function. Thus, both lines of experi-
mentation suggest that the ability of Cln3 to promote Start has
no correlation with its ability to activate transcription when
artificially recruited to the promoter of a reporter gene.
Mutational analysis of SWI6. To better understand the role
of Swi6 as a component of SBF and MBF and as a mediator of
Cln3 function, a mutational analysis of SWI6 was performed.
Various domains of Swi6 were deleted in the context of a
Gal4BD-Swi6 fusion protein. These deletion constructs were
then tested for various aspects of Swi6 function by using a
variety of assays, including the ability to activate transcription
of Gal4-driven reporter genes, the ability to rescue swi4 swi6,
bck2 swi6, and bck2 cln3 swi6 strains, and responsiveness to
CLN3 (Fig. 9). The results of these assays are summarized in
Fig. 9B. The ability of the various GAL4BD-SWI6 mutants to
activate Gal4-driven reporter genes suggested that Swi6 has at
least two domains that can activate transcription: a powerful
transactivating domain between aa 561 and 715 (probably ex-
cluding the leucine zipper region from aa 583 to 610) and a
minor transactivating domain at its amino terminus (aa 193 to
FIG. 7. Cln3 and Swi6 do not coimmunoprecipitate. Strain
RN200-6d (cdc34-2) was transformed with the following plasmid com-
binations: (i) YEplac195 and pHW263 [YEplac181-SWI6-6x(myc)]
(lanes 1 and 5), (ii) pMT41 [YEp24-GAL1-CLN3-3x(HA)] and
pHW262 [YEplac181-SWI6] (lanes 2 and 6), (iii) pMT41 and pHW263
(lanes 3 and 7), and (iv) C2691 [Ycplac33-GAL1-SWI4-3x(HA)] and
pHW263 (lanes 4 and 8). Doubly transformed strains were grown to
early log phase at 24°C in SCuraleu with 2% raffinose. Galactose
was added to 2%, and after another hour of growth at 24°C, cells were
harvested for analysis. Flow cytometry indicated that about half of the
cells in each strain had unreplicated DNA. Protein extracts were an-
alyzed on immunoblots directly (40 g per sample) or, alternatively,
immunoprecipitated (IP) (6 mg per sample) with monoclonal antibod-
ies 12CA5 (anti-HA [-HA]) (A) and 9E10 (-myc) (B) before im-
munoblotting. Immunoblots were performed with antibodies 9E10 (-
myc) (A), 12CA5 (-HA) (B), and sc-53 (Santa Cruz Biotechnology;
polyclonal -PSTAIRE). The -PSTAIRE antibody recognized a
number of bands; in the immunoblot sections shown, the lower band
corresponds to Cdc28. The -HA antibody recognized a nonspecific
band in all samples as well as epitope-tagged versions of Cln3 and Swi4
in the corresponding lanes (B). The ladder of bands below the signal
corresponding to full-length epitope-tagged Swi4 presumably repre-
sents degradation products of epitope-tagged Swi4 (panel B, lane 4).
Because Swi4 was epitope tagged at its amino terminus and its inter-
action with Swi6 occurs at the carboxyl terminus, most of these trun-
cated forms are not coimmunoprecipitated with epitope-tagged Swi6
(panel B, lane 8).
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FIG. 8. Fusion to the Tup1 transcriptional repression domain does not inhibit Cln3’s function. (A and B) Plasmid pHW364 ({CEN-CLN3-
TUP1}) was compared to pHW254 ({CEN-CLN3}) and Ycplac111 ({CEN-vector}) for its ability to regulate cell size (A) and cell cycle distribution
(B) in strain YHW623 (PJ69-4A cln3). Transformants of YHW623 were grown to log phase in SCleu with 2% glucose and examined for cell size
(A) and DNA content (B). (C) The same plasmids were introduced into strain YHW731 (PJ69-4A cln3 {GAL4BD-CDC28}). Transformants of
YHW731 were streaked on plates of SChis with 2% glucose and 3 mM 3-amino-1,2,4-triazole (3-AT) to test for induction of the two-hybrid HIS3
reporter gene of YHW731. As a control, plates of SCleu with 2% glucose were used. The pictures were taken after 4 days of incubation at 30°C.
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281) (Fig. 9A and B). The ankyrin repeats of Swi6 are not
required for transcriptional activation (Fig. 9A and B). Unlike
the construct carrying full-length SWI6, none of the deletion
mutants generated were capable of rescuing the viability of the
swi4 swi6 strain (Fig. 9A and B). A number of mutants, how-
ever, were shown to be partially functional in other assays. For
example, GAL4BD-SWI6NA (GAL41-147-SWI6561-803),
GAL4BD-SWI6NALZ (GAL41-147-SWI6561-583/610-803), and
GAL4BD-SWI6NLZ (GAL41-147 -SWI6284-583/610-803) were
all capable of rescuing viability in a bck2 swi6 strain (Fig. 9A
and B).
Strikingly, deletion mutants simultaneously lacking both the
N-terminal domain and the leucine zipper (GAL4BD-
SWI6NALZ and GAL4BD-SWI6NLZ) were able to res-
cue a bck2 swi6 cln3 strain; that is, they did not require CLN3
in order to promote transcription (Fig. 9A and B). In addition,
these two alleles of GAL4BD-SWI6 were defective in modu-
lating cell size in response to CLN3 (Fig. 9A and B). Thus,
these two versions of Swi6 behave as if they have lost the ability
to respond to CLN3, and they no longer require CLN3 for
transactivation. By comparison, two similar alleles that retain
the leucine zipper, GAL4BD-SWI6NA and GAL4BD-SWI6,
are both capable of mediating cell size control by Cln3 and are
less effective in rescuing bck2 cln3 swi6 (Fig. 9A and B). Thus,
it appears that the leucine zipper of Swi6 may have a role in
mediating the activation of SBF and MBF by Cln3.
The roles of the leucine zipper and the amino terminus of
Swi6 were further analyzed by creating more specific deletions
in otherwise wild-type SWI6 (Fig. 9A and C). These mutants
were tested for the ability to rescue bck2 swi6 and swi4 swi6
mutants and for the ability to mediate Cln3’s control of cell
size. The results of this analysis (Fig. 9A and C) support the
previous results obtained with mutants in the GAL4BD-SWI6
context. Moreover, by including mutant SWI6LZ
(SWI61-561/610-803) in this analysis, the effect of deleting the
leucine zipper region could be determined in an otherwise
wild-type context. Surprisingly, SWI6LZ could mediate size
control by Cln3 (Fig. 9A and C). Thus, it is possible to delete
either the amino-terminal 561 aa (including the nuclear local-
ization signal and ankyrin repeats) or the leucine zipper of
Swi6 without blocking Cln3 from regulating cell size, but if
these two deletions are combined, the resulting Swi6 protein
becomes incapable of mediating this Cln3 function.
DISCUSSION
Cln3 acts via Swi6. The experiments described here have
shown that all known aspects of Cln3’s function, including
control of cell size, pheromone sensitivity, cell cycle progress,
and transcription, require the Swi6 component of SBF and
MBF. Consistent with the epistasis of swi6 to cln3, the effect of
disrupting the SWI6 gene in various genetic backgrounds (cln1
cln2 [43], swi4 [43], bck2 [12], and sit4 [18]) is at least as severe
as that of a cln3 mutation.
In a swi6 mutant, expression of CLN3 at wild-type levels has
no detectable effect whatsoever. However, very high levels of
expression of CLN3 or the stabilized allele CLN3-1 do have
some SWI6-independent effects on pheromone sensitivity and
the timing of DNA replication (Fig. 3) (H. Wijnen and B.
Futcher, unpublished results). At artificially high levels, Cln3
can probably mimic the role of Cln1 and Cln2 and phosphor-
ylate some of their substrates. Mislocalization to the cyto-
plasm, which is expected to occur at high expression levels, has
been shown to allow Cln3 to partially substitute for Cln1 and
Cln2 (15, 38, 39). A Swi6-independent effect of Cln3 overex-
pression on the timing of DNA replication could be explained
by direct phosphorylation and subsequent degradation of the
replication inhibitor Sic1. It is unlikely, however, that Cln3
plays a Swi6-independent role in the degradation of Sic1 under
wild-type conditions, because swi6 and swi6 cln3 mutants have
similar cell cycle defects and because Cln2 is much more effi-
cient than Cln3 at suppressing the phenotype of Sic1 overex-
pression (31).
Spellman and coworkers (57) noted that CLN3 seems to
have some repressive effect on genes expressed late in the cell
cycle (see Fig. 6 of reference 57). We have not tested whether
this putative repressive mitotic function of CLN3 requires SWI6.
The effect of CLN3 on SBF/MBF-mediated transcription
appears to be indirect. Cln3 requires Cdc28 for its ability to
activate SBF and MBF, but it remains unclear what substrates
need to be phosphorylated for this activation. Neither Swi4 nor
Swi6 appears to be activated by Cln3-dependent phosphoryla-
tion. Mutation of putative Cdc28 phosphorylation sites in Swi6
as described in this study and elsewhere (54) does not block the
responsiveness of Swi6 to CLN3. Although we cannot exclude
the possibility that Cln3 activates Swi6 via phosphorylation of
a site that does not match the Cdc28 recognition consensus,
this appears to be unlikely because phosphopeptide analysis
TABLE 3. Analysis of GAL4::CLN3 constructs for transactivation and functiona
Construct Mutation(s)
Induction of Gal4-driven reporter genes on:
Rescue of
bck2 cln3His with: Ura
10 mM 3-AT 30 mM 3-AT 50 mM 3-AT
pPC97     
pHW355     
pHW355 C380stop     
pHW355 L42S C180R     
pHW355 H67R K199R F220L L309S / /   /
a pPC97 (LEU2-CEN-ADH::GAL41–147), pHW355 (pPC97/CLN3-1::3xHA), and the specified mutant derivatives of pHW355 were introduced into strains MAV99
(GAL1::HIS3 SPO13::10xGAL4site::URA3) and YHW204 (bck2 cln3 {pRS313/MET3-CLN2}). Reporter gene expression was estimated by assessing growth of the
MAV99 transformants on SCleuhis with 10, 30, or 50 mM 3-amino-1,2,4-triazole (3-AT) and SCleuura. Rescue of bck2 cln3 was assayed by growth of the
YHW204 transformants on SCleu with 2mM Met.
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has failed to detect cell cycle-regulated phosphorylation out-
side of serine 160 (54). Similarly, we cannot exclude the pos-
sibility that phosphorylation of one of the many SP or TP sites
in Swi4 other than S159 or T799 is involved, but again, such
phosphorylation has not been detected.
Stable complexes containing both Cln3 and Swi6 have not
been detected, even under conditions where both proteins are
active and expressed at high levels. The possibility that activa-
tion of SBF and MBF by Cln3 involves a temporary and weak
physical interaction is difficult to rule out. Our results suggest,
however, that Cln3 is not directly involved in activating tran-
scription at SBF/MBF-driven promoters. Manipulation of the
CLN3 gene to delete its putative transcriptional activation
motifs or to add a transcriptional repression domain did not
alter its function.
The amino terminus and leucine zipper of Swi6 play a role
FIG. 9. Functional analysis of swi6 deletion mutants. (A) Domain structures of the proteins encoded by wild-type SWI6 and a series of deletion
mutants. Swi6 contains five matches (1, 3, 2, 4, and 5) to the minimal consensus (S/T-P) for a Cdc28 phosphorylation site. In addition, Swi6 contains
a domain with four ankyrin repeats (AR), a leucine zipper domain (LZ), and a carboxy-terminal domain for interaction with Swi4 and Mbp1 (CT).
(B) Analysis of GAL4BD-SWI6 deletion mutants. The GAL4BD-SWI6 mutants described in panel A were tested for their ability to activate
transcription of Gal4-driven reporter genes (transactivation); their ability to rescue the growth defects of swi4 swi6, bck2 swi6, and bck2 cln3 swi6
strains, and their ability to mediate Cln3’s control of cell size. Strain YHW668 (PJ69-4A cln3 swi6) was used to assay the abilities of the mutants
to activate the GAL1-HIS3 and GAL2-ADE2 reporter genes. The same strain was used together with the empty vector control YCplac111 or the
single-copy CLN3 plasmid pHW254 (YCplac111-CLN3Not
I
) to assay the ability of the mutants to modulate cell size in response to CLN3. Reporter
gene activation was scored using serial dilutions on plates of SCade with 2% glucose and of SChis with 2% glucose containing various amounts
of 3-amino-1,2,4-triazole (3-AT) (transactivation). Cell size was measured using a Coulter Channelyzer. Strains YHW838 (swi4 swi6
CLN2::MET3-CLN2), YHW541 (bck2 swi6 {MET3-CLN2-CEN}), and YHW613 (bck2 cln3 swi6 {MET3-CLN2-CEN}) were transformed with the
set of GAL4BD-SWI6 mutant plasmids, and suppression of their growth defects was estimated from the ability of the transformants to grow on
plates of SC with 2 mM Met and 2% glucose plates (rescue). (C) Functional analysis of SWI6 deletion mutants. The swi6 deletion mutants shown
in panel A were tested for their abilities to rescue the growth defects of swi4 swi6 and bck2 swi6 strains and for their ability to mediate regulation
of cell size by Cln3. The YCplac33-based deletion mutant plasmids pHW197, pHW206, pHW378, and pHW379 were used to transform YHW228
(swi4 swi6 CLN2::MET3-CLN2) and YHW541 (bck2 swi6 {MET3-CLN2-CEN}). Suppression of the growth defects of YHW228 and YHW541 was
tested on plates of SC with 2 mM Met and 2% glucose (rescue). The YIplac204-based deletion mutant plasmids pHW377, pHW386, pHW387, and
pHW388 were integrated at the trp1 loci of isogenic strains YHW97 (swi6) and YHW446 (cln3 swi6). Log-phase YAPD-grown cultures of the
resulting integrants were used to analyze the effect of the mutations on Cln3-mediated cell size control.
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in Cln3 function. Our mutational analysis of SWI6 has pro-
vided an estimate of the location and strength of Swi6’s tran-
scriptional activation domains that is largely in agreement with
previously reported results (52). More importantly, however,
our analysis has uncovered features of Swi6 that allow it to
mediate Cln3’s function. By employing two independent as-
says, i.e., CLN3-dependent rescue of bck2 swi6 and mediation
of CLN3-responsive change in cell size, we identified two re-
gions of Swi6 with a role in mediating Cln3’s function: (i) the
amino terminus (aa 1 to 284) and (ii) the leucine zipper (aa 583
to 610). Either of these two regions can be deleted without
blocking Cln3 function, but if both are deleted simultaneously,
the resulting mutant Swi6 becomes insensitive to Cln3 while
maintaining part of its transcriptional activity. It is not obvious
why the amino terminus and leucine zipper of Swi6 should
have overlapping functions or how Cln3 would act on either of
these two regions.
One possible model is that both the amino terminus and the
leucine zipper of Swi6 contribute to the interaction of SBF or
MBF with another protein and that this interaction is somehow
the target of Cln3. More specifically, some repressive protein
or protein complex could bind to SBF, using interactions with
both the amino terminus and leucine zipper of Swi6, and this
repressive protein would mask the native transcriptional activ-
ity of SBF. Cln3-Cdc28 could interfere with the binding of the
repressive protein to SBF, thus freeing SBF as an activator.
An attractive feature of this model is that it is analogous to
the situation in mammalian cells. The function of cyclin-Cdk
complexes in regulating cell cycle entry has been conserved
throughout eukaryotes (42, 44). In both budding yeast and
mammals, G1 cyclins and their associated Cdks activate a tran-
scriptional program associated with cell cycle entry (53). In
mammals, cyclin-Cdk complexes activate the E2F-DP tran-
scription complexes (20), just as Cln3-Cdc28 activates SBF and
MBF (29, 36). Mammalian G1 cyclin-Cdk complexes work by
phosphorylating and neutralizing the pocket proteins Rb,
p107, and p130, which bind to and inhibit E2F-DP transcrip-
tion complexes (20). Similarly, we propose that Cln3-Cdc28
may neutralize a protein that binds to and inhibits SBF.
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